Emergent BioSolutions | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
ALKERMES USD 257.31M 110.81M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amarin USD 25.13M 1.78M 2025-03
ANI Pharmaceuticals USD 124.08M 13.79M 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Exact Sciences USD 500.55M 71.25M 2025-03
Exelixis USD 536.28M 10.51M 2025-04
Glaxosmithkline GBP 5.6B 94M 2024-12
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
Lonza CHF 1.04B 72M 2024-12
Merck USD 12.77B 849M 2025-03
Moderna USD 17M 403M 2025-03
Myriad Genetics USD 134.2M 16.7M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Pacira USD 134.62M 12.75M 2025-03
Pfizer USD 11.12B 987M 2025-03
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
United Therapeutics USD 701.9M 41.9M 2025-03



Emergent BioSolutions Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.